Robust immune response to SARS ‐ CoV ‐2 mRNA vaccines may exacerbate the clinical symptoms of A20 haploinsufficiency
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 26.05.2025. Verfasst von Kotaro Sakaya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Postgraduate Education and Training, National Center for Child Health and Development, Tokyo, Japan. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Postgraduate Education and Training, National Center for Child Health and Development, Tokyo, Japan.
- Division of Immunology, National Center for Child Health and Development, Tokyo, Japan.
ORCID-Profile: Kotaro Sakaya, Takashi Ishikawa, Toshinao Kawai
Zitieren
APA
Sakaya, K., Ishikawa, T., Okai, M., Uchiyama, T., Kawai, T., Ishiguro, A., & Onodera, M. (2025). Robust immune response to SARS ‐ CoV ‐2 mRNA vaccines may exacerbate the clinical symptoms of A20 haploinsufficiency. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70065
Vancouver
Sakaya K, Ishikawa T, Okai M, Uchiyama T, Kawai T, Ishiguro A, et al. Robust immune response to SARS ‐ CoV ‐2 mRNA vaccines may exacerbate the clinical symptoms of A20 haploinsufficiency. Pediatrics International. 2025;67(1). doi:10.1111/ped.70065
BibTeX
@article{Sakaya2025,
author = {Sakaya, Kotaro and Ishikawa, Takashi and Okai, Masashi and Uchiyama, Toru and Kawai, Toshinao and Ishiguro, Akira and Onodera, Masafumi},
title = {Robust immune response to SARS ‐ CoV ‐2 mRNA vaccines may exacerbate the clinical symptoms of A20 haploinsufficiency},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70065}
}
EUVIMED